- Tumors988
- Pathology678
- Pathologic Processes663
- Cancer596
- Nervous System Diseases558
Any
<10 miles
<30 miles
<50 miles
<70 miles
Filter Results
Condition
- Tumors988
- Pathology678
- Pathologic Processes663
- Cancer596
- Nervous System Diseases558
Where are you looking?
How far are you willing to travel?Any
How old are you?
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
- HER2 negative
- PD-L1 positive
- ER positive
- HER2 positive
- PD-L1 negative
- EGFR negative
- EGFR positive
- PR positive
- ALK negative
- KRAS positive
- ER negative
- PR negative
- BRAF positive
- BRCA1 positive
- BRAF negative
- CD20 positive
- ROS1 negative
- BRCA2 positive
- p16 positive
- ALK positive
- MET positive
- MYC positive
- PIK3CA positive
- RET positive
- HLA positive
- ROS1 positive
- p16 negative
- BCL2 positive
- HR positive
- PALB2 positive
- BCL6 positive
- HLA-A positive
- IDH negative
- MET negative
- TP53 positive
- BCR-ABL1 positive
- HBsAg positive
- RET negative
- TP53 negative
- dMMR positive
- Anti-dsDNA positive
- BRCA1 negative
- Ex19del positive
- HPV negative
- IDH positive
- L858R positive
- NRAS positive
- TTR positive
- ABCA4 positive
- ANA positive
- BRCA positive
- BRCA2 negative
- CCND1 positive
- CFTR positive
- CLDN18.2 positive
- FGFR2 positive
- HLA negative
- HLA-A negative
- KRAS negative
- MDM2 positive
- MSI-H positive
- MSS positive
- NTRK negative
- NTRK positive
- PTEN positive
- RAS positive
- RB1 negative
- RB1 positive
- T790M positive
- TROP2 negative
- TROP2 positive
- ctDNA positive
- APP positive
- C5 positive
- CD19 positive
- CD5 positive
- COL7A1 positive
- EBV positive
- FMR1 positive
- HPV positive
- MGMT negative
- MMR positive
- NF1 positive
- PSEN1 positive
- PSEN2 positive
- Philadelphia Chromosome positive
- RAS negative
- RF positive
- RHO positive
- pMMR positive
- t(11;14) positive
- β-thalassemia positive
- 11q negative
- 11q positive
- AKT negative
- ALPL positive
- ATM positive
- Aβ1-42 positive
- CD23 positive
- CDK4 positive
- COL1A1 positive
- COL1A2 positive
- DLL3 positive
- DMD positive
- Del(17p) negative
- ER/PR positive
- FLT3 negative
- FOXO1 fusion negative
- FVIII positive
- G719X positive
- GBA positive
- GLA positive
- GRN positive
- HBB positive
- HBV DNA negative
- HEXA positive
- HEXB positive
- HPV16 positive
- HRAS positive
- HRD positive
- HbE positive
- HbSS positive
- IGHV negative
- IGHV positive
- JAK2 positive
- KIT positive
- L861Q positive
- MGMT positive
- MLH1 positive
- MMR negative
- MSH2 positive
- MSH6 positive
- MSI-H negative
- MYC negative
- NF2 positive
- NRAS negative
- PDE6A positive
- PDE6B positive
- PIK3CA negative
- PIK3CD positive
- PIK3R1 positive
- PKLR positive
- PMM2 positive
- PMS2 positive
- PTCH1 positive
- PTEN negative
- Philadelphia chromosome negative
- PiZZ positive
- RAF positive
- S768I positive
- SMN1 positive
- SPINK5 positive
- TTR negative
- anti-AChR positive
- anti-MuSK positive
- anti-PLA2R positive
- anti-Ro autoantibodies positive
- anti-Ro/SSA positive
- anti-Sm positive
- anti-Smith positive
- dMMR negative
- other sickle cell syndrome variants positive
- p53 positive
- 11q del negative
- 12 negative
- 12 positive
- 13q del negative
- 13q negative
- 13q positive
- 16p11.2 deletion positive
- 17p negative
- 17p positive
- 17p13 deletion negative
- 19q negative
- 19q positive
- 1p negative
- 1p positive
- 1p/19q co-deletion positive
- 1p/19q loss positive
- 1p36 deletion positive
- 46 XX karyotype positive
- 5q SMA positive
- 5q-autosomal recessive SMA positive
- AAVrh74 antibody titers negative
- ABL-class fusion positive
- ABL-class fusions positive
- ABO negative
- ABO positive
- ACVR1 positive
- AChR positive
- AChR-Ab positive
- ADAMTS-13 negative
- ADAMTS-13 positive
- AFP positive
- AGXT positive
- AKT positive
- AKT1 positive
- ALT positive
- APOL1 positive
- AQP4 positive
- Gleason Score 10
- Gleason Score 6
- Gleason Score 7
- Gleason Score 8
- Gleason Score 9
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Stage IV
- Stage III
- Stage II
- Stage I
- 1927nm Fractional Thulium Laser Treatment
- Adjuvant Therapy (except reconstruction)
- Anti-HER2 Therapy
- Anti-Seizure Medications (up to 2 types)
- Any Treatment for Pancreatic Cancer
- At least one prior tumor-directed therapy
- Avoidance of Activities That Cause Joint Pain
- Beovu
- Biologic Anti-Neoplastic Agent
- Branch Retinal Vein Occlusion (BRVO)
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
3611 trials
1
2
3
…50